Peripheral arterial disease enters the biomarker era. Does risk stratification tell us something that we don't already know?

European Heart Journal

Volumn 29, Issue 2, 2008, Pages 150-152

  Gornik, Heather L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; MYELOPEROXIDASE;

ANKLE BRACHIAL INDEX; ARTERY DISEASE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; EDITORIAL; ELECTROCARDIOGRAPHY; HUMAN; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STROKE;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; HUMANS; PERIPHERAL VASCULAR DISEASES; PEROXIDASE; RISK ASSESSMENT;

EID: 38349169663     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm535     Document Type: Editorial

References (2)

1. Golomb BA, Dang TT, Criqui MH. Peripheral arterial disease: morbidity and mortality implications. Circulation 2006;114:688-699.
2. Belch JJ, Topol EJ, Agnelli G, Bertrand M, Califf RM, Clement DL, Creager MA, Easton JD, Gavin JR 3rd, Greenland P, Hankey G, Hanrath P, Hirsch AT, Meyer J, Smith SC, Sullivan F, Weber MA; Prevention of Atherothrombotic Disease Network. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 2003;163:884-892.